Highlight
Successful together – our valantic Team.
Meet the people who bring passion and accountability to driving success at valantic.
Get to know usESG transformation with valantic
The Dr. Wolff Group developed a scalable ESG roadmap with valantic. The project focused on a structured status quo analysis, the definition of central KPIs and the integration of sustainability into processes, systems and organization – flanked by practical quick wins.
Challenge
Translation of dynamic ESG requirements into corporate practice and integration into existing processes and structures.
Consulting approach
Holistic status quo analysis, development of individual formats, deep dives for implementation, KPI definition and interactive roadmap.
Customer benefits and solution
Scalable ESG roadmap, central KPIs, concrete quick wins and organizational anchoring of the ESG transformation.
Strategic sustainability orientation at Dr. Wolff with valantic
Dr. Wolff is a family-run company with an international focus. The challenge was to transfer the diverse ESG requirements into existing company processes in a structured and practical manner. Uncertainties in dealing with ESG in the organization arose from the dynamic legal situation, internal restructuring and the complexity of the issues. The aim was to strategically align sustainability efforts and anchor them with measurable measures.
“The collaboration with valantic gave us exactly the right impetus at an important time. We had reached our limits in the implementation of the ESG requirements and decided in favor of valantic due to their strong content expertise.” – Dr. Stefan Kleinebekel, VP Corporate Governance Systems and Sustainability, Dr. Wolff
Status quo analysis and benchmarking against market competitors
Development of a best practice catalog and creation of an ESG database
Carrying out deep dives to define specific measures
Definition of central ESG KPIs and practical quick wins
Conception of an interactive ESG roadmap for strategic anchoring
The ESG roadmap focused on scalability and seamless integration into existing company processes. The aim was to ensure operational implementation as well as data quality and automation in the long term.
With valantic, the Dr. Wolff Group created a solid foundation for its ESG transformation. The systematic approach and intensive sparring led to rapid results while simultaneously setting the strategic course. The joint project defined central KPIs, strengthened the ESG database and adopted a clear roadmap.
The Dr. Wolff Group is one of the largest medium-sized family companies in the German pharmaceutical and cosmetics market. With well-known brands such as Alpecin, Linola and Vagisan, the company operates internationally and is on a dynamic growth path. Dr. Wolff employs over 900 people worldwide and combines scientific excellence with a clear focus on values (as of July 2025). The company pursues the goal of anchoring sustainability as an integral part of its business activities – strategically, organizationally and process-oriented.